FIELD: chemistry.
SUBSTANCE: 17β-oxoestratrienes of the general formula III and 17β-oxyestratrienes of the general formula II are used as intermediary products in obtaining 17α-alkyl-17β-oxyestra-1,3,5(10)-trienes of the general formula I with antiestrogenic effect, where Hal, R3, SK, R17', R17" represent elements listed in the invention claims.
EFFECT: improved method of obtaining the product.
19 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
17α-ALKYL-17β-HYDROXYESTRATRIENES, THEIR USING AND PHARMACEUTICAL PREPARATION | 2002 |
|
RU2285009C2 |
DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2139885C1 |
BRIDGE-CONTAINING ESTRATRIENES | 1990 |
|
RU2087479C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE | 1995 |
|
RU2179442C2 |
COMPOUNDS WITH HYDROXYCARBONYL-HALOGENALKYL BY-SIDE CHAINS | 2000 |
|
RU2247106C2 |
15β-SUBSTITUTED STEROIDS WITH SELECTIVE OESTROGENIC ACTIVITY | 2005 |
|
RU2386637C2 |
15,15-DIALKYLSTEROID COMPOUNDS AND METHOD OF PREPARATION THEREOF | 1994 |
|
RU2147306C1 |
COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
17-DIFLUOROMETHYLENE-EXTRATRIENES: COMPOUNDS AND METHOD OF PREPARATION THEREOF | 1996 |
|
RU2155770C2 |
19-NORSTEROID DERIVATIVES, METHODS OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND INTERMEDIATE COMPOUNDS | 1992 |
|
RU2111213C1 |
Authors
Dates
2008-11-27—Published
2002-11-27—Filed